Keyphrases
Lung Transplantation
100%
Chronic Lung Allograft Dysfunction
93%
Bronchoalveolar Lavage
36%
Acute Cellular Rejection
27%
Tumor
22%
Neutrophils
22%
Tumor-associated Neutrophils
21%
Transbronchial Biopsy
20%
Retrospective Cohort Study
19%
Acute Rejection
18%
Clinically Stable
17%
Single Center
16%
Interstitial Lung Disease
13%
Multivariable
12%
Antitumor
12%
CD8+ T Cells
12%
COVID-19
11%
Heart Transplantation
11%
International Society
11%
Risk Stratification
11%
Median Time
11%
Computed Tomography
10%
Microaspiration
10%
Classification System
10%
Circulating Neutrophils
10%
Bile Acids
10%
Bronchoalveolar Lavage Fluid
10%
Tumor Progression
10%
Low-density Neutrophils
9%
Restrictive Allograft Syndrome
9%
Retransplant
9%
In Cancer
9%
Opacity
7%
Allograft Dysfunction
7%
Tumor Microenvironment
7%
High Risk
7%
Graft Failure
7%
Tumor Growth
7%
Cox Proportional Hazards Model
7%
Sarcoidosis
6%
Prognostic Value
6%
Pulmonary Function Test
6%
Adverse Outcomes
6%
Adaptive Immune Response
6%
Neutrophil Subpopulations
6%
Neutrophil Subsets
6%
Myeloid-derived Suppressor Cells
6%
Bronchoalveolar
6%
Single Lung Transplant
6%
Reduced Survival
6%
Medicine and Dentistry
Lung Transplantation
85%
Allograft
82%
Lung
81%
Lung Lavage
28%
Acute Graft Rejection
27%
Computer Assisted Tomography
17%
Transbronchial Biopsy
14%
Retrospective Cohort Study
13%
Biopsy Technique
11%
Risk Stratification
11%
Heart Transplantation
10%
Patient Referral
10%
Interstitial Lung Disease
10%
Cytokine
10%
Epithelial Cell
7%
Proportional Hazards Model
7%
Sarcoidosis
6%
Adverse Outcome
6%
Cell Death
6%
Cancer
5%
Cytomegalovirus
5%
Bronchiectasis
5%
Fine-Needle Aspiration
5%
Lung Function
5%
Total Lung Capacity
5%
COVID-19
5%
Viremia
5%
Kidney Graft
5%
Acute Kidney Injury
5%
Mediastinal Lymph Node
5%
Endobronchial Ultrasonography
5%
Human Leukocyte Antigen
5%
Extracorporeal Membrane Oxygenation
5%
Prognostic Assessment
5%
Cohort Analysis
5%
Single Nucleotide Polymorphism
5%
Acute Renal Failure
5%
N95 Respirator
5%
Chest Tube
5%
Selective Serotonin Reuptake Inhibitor
5%
Elderly Population
5%
Serotonin-Norepinephrine Reuptake Inhibitor
5%
Reflux
5%
Lung Biopsy
5%
Bleeding
5%
Gastroesophageal Reflux
5%
Bile Acid
5%
Eosinophil
5%
Rituximab
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Immunology and Microbiology
Allograft
99%
Lung Transplantation
87%
Neutrophil
33%
Acute Graft Rejection
32%
Cytokine
12%
Cytotoxic T-Cell
11%
Computer Assisted Tomography
10%
Bronchoalveolar Lavage Fluid
8%
Myeloid-Derived Suppressor Cell
6%
Regulatory T Cell
6%
Airway
6%
Cell Death
6%
Gene Expression Assay
6%
Programmed Cell Death
5%
Cytomegalovirus
5%
Adaptive Immune System
5%
Tumor Necrosis Factor
5%
Hemoglobin Blood Level
5%
Viremia
5%
Single Nucleotide Polymorphism
5%
Tacrolimus
5%
Human Leukocyte Antigen
5%
Albumin Level
5%
Microflora
5%
Immunotherapy
5%
Systolic Blood Pressure
5%
Receptor Blocking
5%
Innate Immune System
5%
Macrophage Activation
5%
Secretion (Process)
5%
CCL17
5%
Eosinophil
5%
Interleukin 6
5%
T-Helper Cell
5%
Cell Population
5%
Neutralizing Antibody
5%
Human Respiratory Syncytial Virus
5%
Respiratory Syncytial Virus Vaccine
5%
Antibody Response
5%
Human Respiratory Syncytial Virus A
5%
Immunosuppression
5%
